Adam Arkin describes the goals of the Center for the Utilization of Biological Engineering in Space (CUBES) project and how their work could enable human life on Mars.
Professor Michael Yartsev’s lab has shown that bats’ brain activity is literally in sync when bats engage in social behaviors like grooming, fighting or sniffing each other. This is the first study to observe synchronized brain activity in a non-human species engaging in natural social interactions, and opens the door to future study on how our brains process social interactions.
The Engineering Biology Research Consortium, a public-private partnership headquartered at UC Berkeley, has released a new roadmap laying out the successes, opportunities and challenges of the maturing field of synthetic biology. It identifies five research areas that the federal government needs to invest in to fuel the bioeconomy and keep the U.S. at the forefront of the field.
Read Professor Amy Herr’s thoughts about Berkeley’s entrepreneurial spirit and “how much we are crushing it.”
BioE MEng alumni Thomas Galeon and Meryll Dindin, with CEE teammate Pierre-Louis Missler were recently featured by the Consumer Technology Association for their creation of AsTeR: a platform for collecting and prioritizing information to facilitate decision making during natural disasters.
Adam Arkin’s lab is working to determine what plants and organisms can be genetically engineered to function and grow into useful products in deep space. Check out Adam’s lab walkthrough video!
Researchers from Professor Kumar’s lab investigate the spreading of cells, offering general regulatory principles that should be directly applicable to understanding and controlling cell spreading in fully 3D environments. This research is applicable to understanding and eventually controlling how tumors spread within the body.
Work by former postdoc Kiana Aran with Profs Murthy and Conboy combines CRISPR with electronic transistors made from graphene to create a new hand-held device that can detect specific genetic mutations in a matter of minutes.
Professor Kevin Healy has been awarded a grant from the FDA through the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI). The grant will cover collaborative research on “Multi-organ microphysiological systems for modeling clinical drug effects.”